Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-185-4 | CAS number: 13680-35-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May - June 1983
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- 4,4'-methylenebis[2,6-diethylaniline]
- EC Number:
- 237-185-4
- EC Name:
- 4,4'-methylenebis[2,6-diethylaniline]
- Cas Number:
- 13680-35-8
- Molecular formula:
- C21H30N2
- IUPAC Name:
- 4,4'-methylenebis(2,6-diethylaniline)
- Test material form:
- solid: crystalline
- Details on test material:
- - Physical state: see above
- Appearance: see above
Constituent 1
- Specific details on test material used for the study:
- TEST MATERIAL
- Substance identification/name in the report: P5256
- Aspect: off-white crystalline solid
- Batch no.: E 29.3.83
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage conditions: Room temperature, protected from light
- Stability under test conditions: stable
- Expiry date: not given
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Manston Road, Margate, Kent, UK
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 6-10 weeks
- Weight at study initiation: males 143-193 g: females 127-177 g
- Fasting period before study: yes
- Housing: caged in groups of 4 by sex for the screening study and in groups of 5 by sex and dose group
- Diet (e.g. ad libitum): SQC Rat and Mouse Maintenance Diet No. 1, Expanded, Special Diets Services Ltd., Stepfield, Witham, Essex, UK
- Water (e.g. ad libitum): tap water
- Acclimation period:5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-21°C
- Humidity (%): 52-70%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): Fluorescent lighting to give a cycle of 12 hours light and 12 hours darkness
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- PRETEST:
Four groups, each of 2 fasted rats (1 male, 1 female), were dosed as follows:
- Dose level 50 mg/kg (Conc. 5 mg/ml) = dose volume 10.00 ml/kg
- Dose level 250 mg/kg (Conc. 25 mg/ml) = dose volume 10.00 ml/kg
- Dose level 1250 mg/kg (Conc. 125 mg/ml) = dose volume 10.00 ml/kg
- Dose level 5000 mg/kg (Conc. 500 mg/ml) = dose volume 10.00 ml/kg
MAIN STUDY:
Five groups, each of 10 fasted rats (5 males, 5 females), were dosed as follows:
- Dose level 1000 mg/kg (Conc. 200 mg/ml) = dose volume 5.00 ml/kg
- Dose level 1410 mg/kg (Conc. 200 mg/ml) = dose volume 7.05 ml/kg
- Dose level 1680 mg/kg (Conc. 200 mg/ml) = dose volume 8.40 ml/kg
- Dose level 2000 mg/kg (Conc. 200 mg/ml) = dose volume 10.00 ml/kg
- Dose level 2830 mg/kg (Conc. 200 mg/ml) = dose volume 14.15 ml/kg - Doses:
- PRETEST:
- Dose level 50 mg/kg
- Dose level 250 mg/kg
- Dose level 1250 mg/kg
- Dose level 5000 mg/kg
MAIN STUDY:
- Dose level 1000 mg/kg
- Dose level 1410 mg/kg
- Dose level 1680 mg/kg
- Dose level 2000 mg/kg
- Dose level 2830 mg/kg - No. of animals per sex per dose:
- PRETEST:
Four groups, each of 2 fasted rats (1 male, 1 female)
MAIN STUDY:
Five groups, each of 10 fasted rats (5 males, 5 females) - Control animals:
- no
- Details on study design:
- APPEARANCE, BEHAVIOUR AND GENERAL OBSERVATIONS:
All animals were observed for overt signs of toxicity or behavioural change at 0.25, 1, 2 and 4 hours after treatment and subsequently once daily for 14 days. All gross or visible toxic or pharmacological effects were recorded.
BODY WEIGHTS:
Individual body weights were recorded on the day before treatment (day -1), on the day of treatment, 7 and 14 days after treatment and at death.
NECROPSY:
All animals were subjected to a gross necropsy examination. No tissues were retained. Animals surviving the 14 day observation period were killed by
exposure to high levels of carbon dioxide. - Statistics:
- The acute oral median lethal dose (LDso) for combined male and female groups were calculated using a probit analysis (Finney, D.J. (1964), Statistical Method for Biological Assay, 2nd Edition, London, Charles Griffin). Separate LDso values were calculated for male and female animals. The mortalities did not allow the calculation of 95% fiducial limits or the production of a dose response curve.
Results and discussion
- Preliminary study:
- Mortalities occured at dose levels of 1250 (50%) and 5000 mg/kg (100%). No mortlaity was noted at 50 and 250 mg/kg. Clinical signs were not determined.
Effect levelsopen allclose all
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 901 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 768 - 2 109
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 736 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 026 mg/kg bw
- Based on:
- test mat.
- Mortality:
- A total of 18 (11 male, 7 female) of the 50 animals died during the study period. All deaths were noted within 5 days after treatment.
- Clinical signs:
- other: All animals treated with 1000 mg/kg appeared normal throughout the study period. All treated animals appeared normal during the day of dosing. Major signs of toxicity noted were lethargy and/or prostration, with occasional signs of piloerection, chromodac
- Gross pathology:
- Major pathological findings in animals dying during the study were associated with the stomach, which appeared distended. The livers were often pale with a speckled appearance and pale kidneys were also noted. With the exception of 1 animal treated with 1000 mg/kg which had dark lungs, and 2 animals treated with 1680 mg/kg which had pale livers, no other abnormalities were noted in animals necropsied at the end of the study period.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The combined LD50 on Wistar rats was found to be 1901 mg/kg; the LD50 for males 1736 mg/kg and for females 2026 mg/kg.
- Executive summary:
The acute oral toxicity was determined in a standard acute toxicity study according to OECD 401 and EC B.1 on male and female Wistar rats. Vehicle was corn oil. The appropriate dose levels were determined in a screening test on one male and female each, using doses of 50, 250, 1250 and 5000 mg/kg. Based on the pretest results, doses of 1000, 1410, 1680, 2000 and 2830 mg/kg were applied to 5 males and 5 females per group in the main study. A total of 18 (11 male, 7 female) of the 50 animals died during the study period. All deaths were noted within 5 days after treatment. All animals treated with 1000 mg/kg appeared normal throughout the study period. All treated animals appeared normal during the day of dosing. Major signs of toxicity noted were lethargy and/or prostration, with occasional signs of piloerection, chromodacryorrhoea, hunched posture and staining around nose and mouth. With the exception of 1 animal treated with 1680 mg/kg all surviving animals showed body weight gains at the end of the study period. Animal 41 lost 36 g at termination. Major pathological findings in animals dying during the study were associated with the stomach, which appeared distended. The livers were often pale with a speckled appearance and pale kidneys were also noted. With the exception of 1 animal treated with 1000 mg/kg which had dark lungs, and 2 animals treated with 1680 mg/kg which had pale livers, no other abnormalities were noted in animals necropsied at the end of the study period.
In conclusion, the combined LD50 on Wistar rats was found to be 1901 mg/kg; the LD50 for males 1736 mg/kg and for females 2026 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
